Global sales for surgical heart valve management products are expected to stay relatively flat by 2023 while percutaneous balloon valvuloplasty (PBV) systems are expected to see double-digit growth, according to a new analysis from Informa's Meddevicetracker titled "Surgical Heart Valve Management Products."
Total worldwide heart valve management product sales are projected to decline at a compound annual growth rate (CAGR) of -0.2%...






